Congenital Adrenal Hyperplasia, 21-Hydroxylase Deficiency - MLPA Analysis

Definition

The CYP21A2 gene encodes the 21-hydroxylase enzyme, which is involved in cortisol and aldosterone synthesis in the adrenal glands. Deficiency of this enzyme accounts for approximately 95% of congenital adrenal hyperplasia (CAH); precursors accumulate and the excess is redirected toward androgen synthesis. The classic form is divided into two subtypes: the salt-wasting form (which can lead to a life-threatening salt-wasting crisis in the newborn) and the simple virilizing form; the non-classic (late-onset) form has the mildest presentation.

Gene/region examined

CYP21A2 - Deletion/Duplication

Method

MLPA Analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Autosomal recessive; a pathogenic variant in both copies of the gene is required for the classic forms to occur, and carrier parents are usually asymptomatic. The classic form occurs in approximately 1 in 15,000 newborns and is included in newborn screening programs.

Related Tests